The Cystinuria drugs in development market research report provides comprehensive information on the therapeutics under development for Cystinuria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Cystinuria. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Cystinuria and features dormant and discontinued products.
GlobalData tracks eight drugs in development for Cystinuria by eight companies/universities/institutes. The top development phase for Cystinuria is preclinical with five drugs in that stage. The Cystinuria pipeline has seven drugs in development by companies and one by universities/ institutes. Some of the companies in the Cystinuria pipeline products market are: Advicenne, Bellvitge Biomedical Research Institute and Spyre Therapeutics.
The key targets in the Cystinuria pipeline products market include Calcium.
The key mechanisms of action in the Cystinuria pipeline product include Calcium Chelator with one drug in Preclinical. The Cystinuria pipeline products include one routes of administration with the top ROA being Oral and four key molecule types in the Cystinuria pipeline products market including Small Molecule, and Biologic.
Cystinuria overview
Cystinuria is an inherited defect characterized by a buildup of the amino acid, cystine, in the kidneys and bladder, that leads to the formation of cystine crystals and/or stones which may block the urinary tract.
For a complete picture of Cystinuria’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
